|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Atopic Dermatitis | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Dermatitis | |||||
| Dermatitis, Atopic | |||||
| 3 | More general conditions related to this trial | ||||
| Genetic Diseases, Inborn | |||||
| Hypersensitivity | |||||
| Hypersensitivity, Immediate | |||||
| Immune System Diseases | |||||
| Skin Diseases | |||||
| Skin Diseases, Eczematous | |||||
| Skin Diseases, Genetic | |||||
| 4 | Interventions listed in this trial | ||||
| Sodium hypochlorite baths | |||||
| Mupirocin ointment | |||||
| Cephalexin | |||||
| Water | |||||
| Petrolatum Ointment | |||||
| 5 | Additional drug interventions recognized in this trial | ||||
| Eusol | |||||
| Mupirocin | |||||
| Petrolatum | |||||
| Sodium Hypochlorite | |||||
| 6 | More general drug interventions related to this trial | ||||
| Anti-Bacterial Agents | |||||
| Anti-Infective Agents | |||||
| Dermatologic Agents | |||||
| Disinfectants | |||||
| Emollients | |||||
| Enzyme Inhibitors | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Pharmacologic Actions | |||||
| Protein Synthesis Inhibitors | |||||
| Therapeutic Uses | |||||
| 7 | Sponsors listed in this trial | ||||
| Children's Memorial Hospital | |||||
| Society for Pediatric Dermatology | |||||
| Johnson &Johnson | |||||